Hemoglobinopathies
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Towards a goal of using recombinant adeno-associated viruses (AAV) for the gene therapy of hemoglobinopathies we had previously constructed plasmid pAV h beta G psi 1, which contained a human beta-globin-encoding cDNA (HBB) downstream from the P40 promoter of AAV2 DNA [Ohi et al., Gene 89 (1990) 279-282].
|
1655580 |
1991 |
Neoplasms
|
0.060 |
Biomarker
|
group |
BEFREE |
Intratumoral or subcutaneous (away from the tumor site) injections of purified epidermal growth factor receptor-related protein caused regression of palpable colon cancer xenograft tumors in some severely compromised immunodeficient mice and arrested tumor growth in others.
|
12730874 |
2003 |
Colorectal Carcinoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
We also studied whether epidermal growth factor receptor-related protein expression is altered in colorectal cancer.
|
12730874 |
2003 |
Adenocarcinoma
|
0.010 |
AlteredExpression
|
group |
BEFREE |
Epidermal growth factor receptor-related protein expression was found to be high in benign human colonic epithelium but low in adenocarcinoma.
|
12730874 |
2003 |
Malignant tumor of colon
|
0.010 |
Biomarker
|
disease |
BEFREE |
Epidermal growth factor receptor-related protein-induced inhibition of proliferation of colon cancer cells was prevented by epidermal growth factor receptor-related protein antibodies.
|
12730874 |
2003 |
Cardiac Arrest
|
0.010 |
Biomarker
|
disease |
BEFREE |
Intratumoral or subcutaneous (away from the tumor site) injections of purified epidermal growth factor receptor-related protein caused regression of palpable colon cancer xenograft tumors in some severely compromised immunodeficient mice and arrested tumor growth in others.
|
12730874 |
2003 |
Colon Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Epidermal growth factor receptor-related protein-induced inhibition of proliferation of colon cancer cells was prevented by epidermal growth factor receptor-related protein antibodies.
|
12730874 |
2003 |
Malignant neoplasm of colon and/or rectum
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
We also studied whether epidermal growth factor receptor-related protein expression is altered in colorectal cancer.
|
12730874 |
2003 |
Malignant neoplasm of breast
|
0.060 |
AlteredExpression
|
disease |
BEFREE |
ErbB2 (epidermal growth factor receptor-related protein B2) is frequently overexpressed in human breast cancer and is sufficient for mammary tumorigenesis in vivo.
|
12810676 |
2003 |
Breast Carcinoma
|
0.060 |
AlteredExpression
|
disease |
BEFREE |
ErbB2 (epidermal growth factor receptor-related protein B2) is frequently overexpressed in human breast cancer and is sufficient for mammary tumorigenesis in vivo.
|
12810676 |
2003 |
Mammary Tumorigenesis
|
0.010 |
AlteredExpression
|
phenotype |
BEFREE |
ErbB2 (epidermal growth factor receptor-related protein B2) is frequently overexpressed in human breast cancer and is sufficient for mammary tumorigenesis in vivo.
|
12810676 |
2003 |
Liver carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Reduced expression of epidermal growth factor receptor-related protein in hepatocellular carcinoma: implications for cancer growth.
|
15205570 |
2004 |
Neoplasms
|
0.060 |
AlteredExpression
|
group |
BEFREE |
Mean scores for ERRP expression decreased significantly across well differentiated, moderately well differentiated and poorly differentiated (P = 0.002) tumors, respectively.
|
15327841 |
2004 |
Carcinogenesis
|
0.010 |
AlteredExpression
|
phenotype |
BEFREE |
Expression of epidermal growth factor-receptor related protein (ERRP) in human colorectal carcinogenesis.
|
15327841 |
2004 |
Malignant Neoplasms
|
0.030 |
AlteredExpression
|
group |
BEFREE |
Expression of ERRP in cancer cells inversely correlated with cell proliferation and grade of malignancy.
|
15647181 |
2005 |
Primary malignant neoplasm
|
0.030 |
AlteredExpression
|
group |
BEFREE |
Expression of ERRP in cancer cells inversely correlated with cell proliferation and grade of malignancy.
|
15647181 |
2005 |
Malignant neoplasm of stomach
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
We examined ERRP expression and localisation in surgical specimens of gastric cancers from 47 patients versus non-malignant gastric mucosa and determined their relationship to cell proliferation and differentiation.
|
15647181 |
2005 |
Neoplasm Metastasis
|
0.010 |
AlteredExpression
|
phenotype |
BEFREE |
Cell lines derived from metastatic gastric cancers had reduced ERRP expression compared with cell lines derived from a non-metastatic cancer.
|
15647181 |
2005 |
Disseminated Malignant Neoplasm
|
0.010 |
AlteredExpression
|
phenotype |
BEFREE |
Cell lines derived from metastatic gastric cancers had reduced ERRP expression compared with cell lines derived from a non-metastatic cancer.
|
15647181 |
2005 |
Stomach Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Because of the causal involvement of EGFR and its ligands in gastric cancer growth, we investigated expression of ERRP and cell proliferation in human gastric cancer.
|
15647181 |
2005 |
Secondary Neoplasm
|
0.010 |
AlteredExpression
|
group |
BEFREE |
Cell lines derived from metastatic gastric cancers had reduced ERRP expression compared with cell lines derived from a non-metastatic cancer.
|
15647181 |
2005 |
Tumor Cell Invasion
|
0.030 |
Biomarker
|
phenotype |
BEFREE |
Epidermal growth factor receptor-related protein inhibits cell growth and invasion in pancreatic cancer.
|
16885366 |
2006 |
Pancreatic carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Epidermal growth factor receptor-related protein inhibits cell growth and invasion in pancreatic cancer.
|
16885366 |
2006 |
Malignant neoplasm of pancreas
|
0.010 |
Biomarker
|
disease |
BEFREE |
Epidermal growth factor receptor-related protein inhibits cell growth and invasion in pancreatic cancer.
|
16885366 |
2006 |
Malignant neoplasm of breast
|
0.060 |
Biomarker
|
disease |
BEFREE |
Silencing the RHBDF1 gene with short interfering RNA (siRNA) results in apoptosis in breast cancer MDA-MB-435 cells and autophagy in head and neck squamous cell cancer 1483 cells.
|
18524845 |
2008 |